0
Summaries for Patients |

Insulin Resistance Is Associated with Abnormalities of Coronary Arteries in People without Other Cardiac Risk Factors FREE

[+] Article and Author Information

The summary below is from the full report titled “Coronary Vasomotor Abnormalities in Insulin-Resistant Individuals.” It is in the 4 May 2004 issue of Annals of Internal Medicine (volume 140, pages 700-708). The authors are M.J. Quiñones, M. Hernandez-Pampaloni, H. Schelbert, I. Bulnes-Enriquez, X. Jimenez, G. Hernandez, R. De La Rosa, Y. Chon, H. Yang, S.B. Nicholas, T. Modilevsky, K. Yu, K. Van Herle, L.W. Castellani, R. Elashoff, and W.A. Hsueh.


Ann Intern Med. 2004;140(9):I-32. doi:10.7326/0003-4819-140-9-200405040-00003
Text Size: A A A

What is the problem and what is known about it so far?

Insulin is a substance made by the pancreas to help the body store energy from food. People with type 2 diabetes mellitus make plenty of insulin, but their bodies cannot use it normally, resulting in high blood sugar levels. Some people do not have type 2 diabetes but have “insulin resistance.” People with insulin resistance do not have the high blood sugar levels that occur in people with type 2 diabetes, but their bodies must produce large amounts of insulin to keep sugar levels normal. Insulin resistance can progress to type 2 diabetes. People with type 2 diabetes have a high risk for heart disease. Some studies suggest that insulin resistance is also associated with heart disease but could not determine whether the higher rates of heart diseases in people with insulin resistance were due to the insulin resistance or to other risk factors for heart disease, such as high blood pressure, smoking, or abnormal cholesterol levels.

Why did the researchers do this particular study?

To see whether people with insulin resistance and no other risk factors for cardiovascular disease are more likely to have abnormalities of the heart's blood vessels than similar people without insulin resistance.

Who was studied?

50 young adults with no risk factors for heart disease except insulin resistance and 22 similarly aged young adults without insulin resistance or other risk factors for heart disease. All study participants were Mexican American.

How was the study done?

First, the researchers determined whether people were insulin-resistant by using a special blood test in which sugar and insulin are delivered through a small tube inserted into an arm vein. Next, they studied the blood flow to the heart by using positron emission tomography, which evaluated the function of the lining and muscular wall of the heart's blood vessels during various situations. In addition, they repeated the tests in 26 of the insulin-resistant people after giving them a medication to treat insulin resistance.

What did the researchers find?

The tests that examined the function of the muscle in the wall of the heart blood vessels showed no differences between insulin-resistant and healthy people. However, the test result of the blood vessel lining was abnormal in insulin-resistant patients. This defect in the vessel lining is important because it is the first step for developing heart disease. These abnormalities went away after the 22 patients received the medication to treat insulin resistance.

What were the limitations of the study?

This study involved a small number of people from one ethnic group. In addition, it examined blood vessel function, not actual heart disease events. Additional studies are necessary to determine whether treating people with insulin resistance before it progresses to diabetes will decrease their chances of developing heart disease.

What are the implications of the study?

Even before diabetes develops, people with insulin resistance and no other risk factors for heart disease have abnormalities of the heart's blood vessels.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Complement C3 as a marker of cardiometabolic risk in psoriasis. Arch Dermatol Res Published online May 22, 2014.;

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)